16S rRNA Profiling of Nine Global New Strains of Staphylococcus aureus Isolated from Clinical Specimens in Basrah Province, Iraq

Main Article Content

Tahrir H. Gadban
Saad S. Al-Amara
Hanadi A. Jasim

Keywords

Staphylococcus aureus, 16SrRNA, new isolates, diabetic foot, hemodialysis. .

Abstract

Background: Staphylococcus aureus is familiar as a common pathogen. It is found worldwide and is a leading cause of disease. Many methods have been used for identifying the associated strains in clinical specimens. Sequencing by 16SrRNA methods is achieved in identification.
Methods: A total of 300 clinical swab samples were collected from diabetic foot infected and hemodialysis patients who were admitted to Basrah General Hospitals during the period from March- 2018 to February 2019. Bacterial isolates were identified and sequencing was done by using a Vitek®2 system and 16SrRNA with specific primers for Staphylococcus genus.
Results: Thirty-six Staphylococcus species comprised 21 (58.3%) isolates determined in diabetic foot patients, while 15 (41.7%) were identified from hemodialysis patients. The 24 isolates were identified as S. aureus. The 16SrRNA showed the nine strains of Staphylococcus aureus isolates (No.1,2,4,6,8,9,17,25 and 26) had many differences when compared with their reference strains. These
isolates were reported as new global separated strains and published by the National Center for Biotechnology Information (NCBI) and European Nucleotide Archive (ENA), as Staphylococcus aureus TSH-Basrah 01, TSH-Basrah 02, TSH-Basrah 04, TSH-Basrah 06, TSH-Basrah 08, TSHBasrah 09, TSH-Basrah 17, TSH-Basrah 25 and TSH-Basrah 26 strain under accession number (MN982864.1, MN982865.1, MN982866.1, MN982867.1, MN982868.1, MN982869.1, MN982870.1 MN982871.1, and MN982872.1) respectively.
Conclusion: Nine global strains of S. aureus were detected from clinical specimens in Basrah. The result of 16S rRNA has given a clear picture of the significance of the Vitek ® 2 system that was used for the identification of S.aureus from clinical samples.

Abstract 264 | pdf Downloads 151

References

1. Abed, A. H. et al. (2018) ‘Genotyping of β - lactams resistant staphylococci isolated from bovine subclinical mastitis’, Beni-Suef
University Journal of Basic and Applied Sciences. Elsevier B.V., 7(4), pp. 499–504. doi: 10.1016/j.bjbas.2018.05.004.
2. Connor, L. O. et al. (2019) ‘Conventional and Rapid Methods for Identification of Staphylococcus aureus from Clinical Specimens’,
Journal of Chemical Information and Modeling, 9(9), p. 969. doi: 10.1017/CBO9781107415324.004.
3. Delmas, J. et al. (2008) ‘Evaluation of the vitek 2 system with a variety of Staphylococcus species’, Journal of Clinical Microbiology, 46(1), pp. 311–313. doi: 10.1128/JCM.01610-07.
4. Deurenberg, R. H. et al. (2017) ‘Application of next-generation sequencing in clinical microbiology and infection prevention, Journal of
biotechnology. Elsevier, 243, pp. 16–24.
5. Drancourt, M. et al. (2000) ‘16S ribosomal DNA sequence analysis of a large collection of environmental and clinical unidentifiable
bacterial isolates’, Journal of Clinical Microbiology, 38(10), pp. 3623–3630. doi: 10.1128/jcm.38.10.3623-3630.2000.
6. Figueras, M. J., Levican, A., and Collado, L. (2012) ‘Updated 16S rRNA-RFLP method for the identification of all currently characterized
Arcobacter spp’, BMC Microbiology, 12. doi: 10.1186/1471-2180-12-292.
7. Layer, F. et al. (2006) ‘Comparative Study Using Various Methods for Identification of Staphylococcus Species in Clinical Specimens’,
Journal Of Clinical Microbiology, 44(8), pp. 2824–2830. doi: 10.1128/JCM.00226-06.
8. MacCannell, D. (2016) ‘Next generation sequencing in clinical and public health microbiology’, Clinical Microbiology Newsletter. Elsevier, 38(21), pp. 169–176.
9. McClure, J. A. et al. (2006) ‘Novel multiplex PCR assay for detection of the staphylococcal virulence marker Panton-Valentine leukocidin genes and simultaneous discrimination of methicillin-susceptible from -resistant staphylococci’, Journal of Clinical Microbiology, 44(3), pp. 1141–1144. doi:10.1128/JCM.44.3.1141-1144.2006.
10. Motro, Y. and Moran-Gilad, J. (2017) ‘Nextgeneration sequencing applications in clinical bacteriology’, Biomolecular detection and
quantification. Elsevier, 14, pp. 1–6.
11. Nimer, N., Al-Saa’da, R. and Abuelaish, O. (2016) ‘Accuracy of the VITEK 2 system for a rapid and direct identification and susceptibility testing of Gram-negative rods and Gram-positive cocci in blood samples’, Eastern Mediterranean Health Journal, 22(3), pp. 193–300. doi:10.26719/2016.22.3.193.
12. Peker, N. et al. (2019) ‘A Comparison of Three Different Bioinformatics Analyses of the 16S – 23S rRNA Encoding Region for Bacterial
Identification’, 10(April), pp. 1–13. doi: 10.3389/fmicb.2019.00620.
13. Petti, C. A. (2007) ‘Detection and Identification of Microorganisms by Gene Amplification and Sequencing’, 44. doi: 10.1086/512818.
14. Rossen, J. W. A., Friedrich, A. W. and MoranGilad, J. (2018) ‘Practical issues in implementing whole-genome-sequencing in routine diagnostic microbiology’, Clinical Microbiology and Infection. Elsevier, 24(4), pp. 355–360.
15. Sabat, A. J. et al. (2017) ‘Targeted nextgeneration sequencing of the 16S-23S rRNA region for culture-independent bacterial
identification-increased discrimination of closely related species’, Scientific reports. Nature Publishing Group, 7(1), pp. 1–12.
16. Sanguinetti, M. et al. (2003) ‘Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum β- lactamase detection method’, Journal of Clinical Microbiology, 41(4), pp. 1463–1468. doi: 10.1128/JCM.41.4.1463-1468.2003.
17. Singh, K. et al. (2019) ‘Methicillin-Resistant Staphylococcus aureus Infections in Patients With Renal Disorders: A Review’, World Journal of Nephrology and Urology, 8(1), pp. 8–13. doi: 10.14740/wjnu384.
18. Stacey, H. J. et al. (2019) ‘The prevalence of methicillin-resistant Staphylococcus aureus among diabetic patients: a meta-analysis’, Acta Diabetologica. Springer Milan, 56(8), pp. 907–921. doi: 10.1007/s00592-019-01301-0.
19. Winand, R. et al. (2019) ‘Targeting the 16S rRNA Gene for Bacterial Identification in Complex Mixed Samples : Comparative Evaluation of Second ( Illumina ) and Third ( Oxford Nanopore Technologies ) Generation Sequencing Technologies’, pp. 1–22. doi: 10.3390/ijms21010298.
20. Woo, P. C. Y. et al. (2008) ‘Then and now : use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories’, European Society of Clinical Infectious Diseases. European Society of Clinical Infectious Diseases, 14(10), pp. 908–934. doi: 10.1111/j.1469- 0691.2008.02070.x.

Most read articles by the same author(s)